Title
Viscerotropic disease following yellow fever vaccination in Peru
Date Issued
09 October 2009
Access level
metadata only access
Resource Type
journal article
Author(s)
Hernández H.
Ropero A.
Waterman S.
Ticona M.
Brinton M.
Uchuya J.
Gershman M.
Toledo W.
Staples E.
Campos C.
Martínez M.
Chang G.
Lanciotti R.
Zaki S.
Montgomery J.
Monath T.
Hayes E.
Publisher(s)
Elsevier
Abstract
Five suspected cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) clustered in space and time following a vaccination campaign in Ica, Peru in 2007. All five people received the same lot of 17DD live attenuated yellow fever vaccine before their illness; four of the five died of confirmed YEL-AVD. The surviving case was classified as probable YEL-AVD. Intensive investigation yielded no abnormalities of the implicated vaccine lot and no common risk factors. This is the first described space-time cluster of yellow fever viscerotropic disease involving more than two cases. Mass yellow fever vaccination should be avoided in areas that present extremely low risk of yellow fever. © 2009 Elsevier Ltd.
Start page
5974
End page
5981
Volume
27
Issue
43
Language
English
OCDE Knowledge area
Medicina tropical
Subjects
Scopus EID
2-s2.0-70349435917
PubMed ID
Source
Vaccine
ISSN of the container
0264410X
Sponsor(s)
Adult; Aged; Fatal Outcome; Female; Humans; Male; Middle Aged; Peru; Risk Factors; Vaccination; Vaccines, Attenuated; Yellow Fever; Yellow Fever Vaccine; Young Adult
Sources of information:
Directorio de Producción Científica
Scopus